According to ASCO/CAP 2018 that considers the HER2 test positive when the tumor specimens showed HER2 IHC 3+ or positive HER2 gene amplification by FISH, we found that 2/26 cases (8%) were HER2 positive. The gene discussed is ERBB2; the disease is neoplasm.